Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Probiotics Lactobacillus Rhamnosus GR-1 and Lactobacillus Reuteri RC-14 Reduce Group B Streptococci Colonization in Pregnant Women

NCT01577108 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT01577108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01577108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Probiotics Lactobacillus Rhamnosus GR-1 and Lactobacillus Reuteri RC-14 Reduce Group B Streptococci Colonization in Pregnant Women
Lead sponsor
China Medical University Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2011
Completion date
July 31, 2013
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

group b streptococcal infection